APYX
Apyx Medical Corp
NASDAQ · Healthcare · Medical - Devices · US
$2.60
−0.19%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$2.57
From 52W high−46.60%
Volume51077.00
Market cap$109.31M
P/E (TTM)—
P/S (TTM)1.9x
Div yield—
Key dataNov 4, 2026
Open
$2.57
From 52W high
−46.60%
Volume
51077.00
Market cap
$109.31M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−75.9x
P/E (TTM)
—
RSI (14)
45.5
MomentumView details →
1D Return
−0.19%
YTD Return
−27.71%
SummaryUpdated Jun 1, 2026
Apyx Medical Corporation (NASDAQ:APYX) is a Florida-based medical device company that was founded in 1982 and originally operated under the name Bovie Medical Corporation before rebranding in January 2019. The company specializes in developing, manufacturing, and selling advanced energy-based medical devices primarily for the cosmetic surgery and surgical markets worldwide. Apyx went public in January 2019 and has positioned itself as a technology leader in the growing aesthetic medicine sector, particularly focusing on minimally invasive procedures for skin tightening and body contouring.
Similar companies
Latest newsMore news →
Apyx Medical Corp announced that it will release its fiscal third-quarter 2026 financial results before markets open on November 5, 2026.13d agoApyx Medical Corporation announced results from a prospective clinical study evaluating the effects of its Renuvion helium plasma radiofrequency technology on biological markers of skin quality.36d ago